191 related articles for article (PubMed ID: 25177788)
1. [Ways of optimizing diuretic therapy in congestive heart failure, chronic place torasemide prolonged release].
Kobalava ZhD; Kiiakbaev GK
Kardiologiia; 2014; 54(4):69-77. PubMed ID: 25177788
[No Abstract] [Full Text] [Related]
2. Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?
Manolis A; Kallistratos M; Doumas M
Curr Pharm Des; 2021; 27(23):2714-2721. PubMed ID: 33823773
[TBL] [Abstract][Full Text] [Related]
3. [Torasemide is the effective loop diuretic for long-term therapy of arterial hypertension].
Preobrazhenskiĭ DV; Nekrasova NI; Khoseva EN; Arystanova A; Talyzina IV; Pataraia SA
Kardiologiia; 2011; 51(4):67-73. PubMed ID: 21623723
[TBL] [Abstract][Full Text] [Related]
4. [Effect of dosage forms loop diuretic with a different release rate for early and delayed the prognosis of patients with circulatory decompensation].
Arutiunov AG; Dragunov DO; Arutiunov GP; Rylova AK; Sokolova AV
Kardiologiia; 2014; 54(9):24-32. PubMed ID: 25702399
[No Abstract] [Full Text] [Related]
5. Torasemide for the treatment of heart failure.
Ishido H; Senzaki H
Cardiovasc Hematol Disord Drug Targets; 2008 Jun; 8(2):127-32. PubMed ID: 18537599
[TBL] [Abstract][Full Text] [Related]
6. Use of the loop diuretic torsemide in three dogs with advanced heart failure.
Oyama MA; Peddle GD; Reynolds CA; Singletary GE
J Vet Cardiol; 2011 Dec; 13(4):287-92. PubMed ID: 22030290
[TBL] [Abstract][Full Text] [Related]
7. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
Kido H; Ohtaki Y
Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
[TBL] [Abstract][Full Text] [Related]
8. [Torasemide--new generation loop diuretic: clinical pharmacology and therapeutic application].
Preobrazhenskiĭ DV; Sidorenko BA; Tarykina EV; Batyraliev TA; Marenich AV
Kardiologiia; 2006; 46(10):75-86. PubMed ID: 17159856
[TBL] [Abstract][Full Text] [Related]
9. Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Ballester MR; Roig E; Gich I; Puntes M; Delgadillo J; Santos B; Antonijoan RM
Drug Des Devel Ther; 2015; 9():4291-302. PubMed ID: 26273191
[TBL] [Abstract][Full Text] [Related]
10. [Diuretic therapy in heart failure].
Trullàs JC; Morales-Rull JL; Formiga F;
Med Clin (Barc); 2014 Feb; 142(4):163-70. PubMed ID: 23768854
[TBL] [Abstract][Full Text] [Related]
11. Dose-response study of intravenous torsemide in congestive heart failure.
Hariman RJ; Bremner S; Louie EK; Rogers WJ; Kostis JB; Nocero MA; Jones JP
Am Heart J; 1994 Aug; 128(2):352-7. PubMed ID: 8037103
[TBL] [Abstract][Full Text] [Related]
12. Torasemide in chronic heart failure: results of the TORIC study.
Cosín J; Díez J;
Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
[TBL] [Abstract][Full Text] [Related]
13. [Effects of various diuretics on cardiac function in rats with heart failure].
Tanaka H; Watanabe K; Harima M; Thanikachalam PV; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
Yakugaku Zasshi; 2009 Jul; 129(7):871-9. PubMed ID: 19571523
[TBL] [Abstract][Full Text] [Related]
14. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
[TBL] [Abstract][Full Text] [Related]
15. Ground Hog Day: Do We Need Another Analysis of Diuretic Dose and Outcomes in Heart Failure Patients?
Page RL; Lindenfeld J
J Card Fail; 2017 Aug; 23(8):594-596. PubMed ID: 28529135
[No Abstract] [Full Text] [Related]
16. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
Reyes AJ; Leary WP
Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
[TBL] [Abstract][Full Text] [Related]
17. [Use of loop diuretics in heart failure: Current aspects].
Kurlykina NV; Seredenina EM; Orlova YA
Ter Arkh; 2017; 89(9):115-119. PubMed ID: 29039840
[TBL] [Abstract][Full Text] [Related]
18. Torasemide. A review of its pharmacological properties and therapeutic potential.
Friedel HA; Buckley MM
Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
[TBL] [Abstract][Full Text] [Related]
19. LOOP DIURETICS IN HEART FAILURE: EVIDENCE-BASED CHOICE.
Rоsul ММ; Bletskan ММ; Ivano NV; Korabelschykova MO
Wiad Lek; 2021; 74(4):1003-1006. PubMed ID: 34156020
[TBL] [Abstract][Full Text] [Related]
20. The pharmacodynamics of torsemide in patients with congestive heart failure.
Vargo D; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
Clin Pharmacol Ther; 1994 Jul; 56(1):48-54. PubMed ID: 8033494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
